Abstract
Several management options are available to patients with stage I seminoma, including adjuvant radiotherapy, surveillance, and adjuvant chemotherapy. We performed a pooled analysis of patients from the four largest surveillance studies to better delineate prognostic factors associated with disease progression.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Clinical Oncology |
Vol/bind | 20 |
Udgave nummer | 22 |
Sider (fra-til) | 4448-52 |
Antal sider | 5 |
ISSN | 0732-183X |
Status | Udgivet - 15 nov. 2002 |